# IntoCell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intocell

- Industry: Pharmaceuticals
- Headquarters: Daejeon, South Korea
- Website: www.intocell.co.kr
- Total disclosed funding: $48M
- Latest round: Series C (Dec 1, 2020)
- Investors on record: 14

## About

Founded in 2015 and based in Daejeon, South Korea, IntoCell operates as a researcher and developer of anti-cancer drugs that utilize linker technology that eliminates cancer cells in the human body. In February 2016, Intocell raised KRW 6 billion in venture funding from new investors Atinum Investment, KNet Investment Partners, Partners Investment, Seoul Investment Partners, and Stonebridge Capital.

## Funding rounds

- Series C, Dec 1, 2020, $31M — Atinum Investment, Seoul Investment Partners, KNet Investment Partners, ST Capital, DA Value Investment, Winvest Venture Capital, Brave New Investment, Orbit Partners, Friend Investment Partners
- Series B, Dec 27, 2019, $0.9M — Mirae Asset Securities
- Series B, May 11, 2018, $9.5M — Daedeok Venture Partners
- Series A, Sep 30, 2016, $1.8M — SL Investment
- Series A, Feb 2, 2016, $5M — Atinum Investment, Seoul Investment Partners, Partners Investment, KNet Investment Partners, Stonebridge Ventures

## Investors

- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series A, Series C
- Seoul Investment Partners (https://capitalatlas.ai/funds/seoul-investment-partners) — Series A, Series C
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series A
- KNet Investment Partners (https://capitalatlas.ai/funds/knet-investment-partners) — Series A, Series C
- Stonebridge Ventures — Series A
- SL Investment (https://capitalatlas.ai/funds/sl-investment) — Series A
- Daedeok Venture Partners (https://capitalatlas.ai/funds/daedeok-venture-partners) — Series B
- Mirae Asset Securities (https://capitalatlas.ai/funds/mirae-asset-securities) — Series B
- ST Capital (https://capitalatlas.ai/funds/st-capital) — Series C
- DA Value Investment (https://capitalatlas.ai/funds/da-value-investment) — Series C
- Winvest Venture Capital (https://capitalatlas.ai/funds/winvest-venture-capital) — Series C
- Brave New Investment (https://capitalatlas.ai/funds/brave-new-investment) — Series C
- Orbit Partners (https://capitalatlas.ai/funds/orbit-partners) — Series C
- Friend Investment Partners (https://capitalatlas.ai/funds/friend-investment-partners) — Series C